CN113069425A - N-乙酰神经氨酸含化糖冻干闪释片及其制备方法 - Google Patents
N-乙酰神经氨酸含化糖冻干闪释片及其制备方法 Download PDFInfo
- Publication number
- CN113069425A CN113069425A CN202110366255.XA CN202110366255A CN113069425A CN 113069425 A CN113069425 A CN 113069425A CN 202110366255 A CN202110366255 A CN 202110366255A CN 113069425 A CN113069425 A CN 113069425A
- Authority
- CN
- China
- Prior art keywords
- acetylneuraminic acid
- freeze
- flash
- release tablet
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 title claims abstract description 65
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- -1 N-acetylneuraminic acid saccharide Chemical class 0.000 claims abstract description 26
- 238000004108 freeze drying Methods 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000853 adhesive Substances 0.000 claims abstract description 11
- 230000001070 adhesive effect Effects 0.000 claims abstract description 11
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims description 17
- 229920001218 Pullulan Polymers 0.000 claims description 13
- 239000004373 Pullulan Substances 0.000 claims description 13
- 235000019423 pullulan Nutrition 0.000 claims description 13
- 238000007710 freezing Methods 0.000 claims description 12
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 11
- 229930195725 Mannitol Natural products 0.000 claims description 11
- 239000000594 mannitol Substances 0.000 claims description 11
- 235000010355 mannitol Nutrition 0.000 claims description 11
- 230000001804 emulsifying effect Effects 0.000 claims description 10
- 235000003599 food sweetener Nutrition 0.000 claims description 9
- 239000003765 sweetening agent Substances 0.000 claims description 9
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 8
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 8
- 230000008014 freezing Effects 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000004376 Sucralose Substances 0.000 claims description 5
- 238000007872 degassing Methods 0.000 claims description 5
- 238000004945 emulsification Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 5
- 235000019408 sucralose Nutrition 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 238000009849 vacuum degassing Methods 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000000843 powder Substances 0.000 abstract description 7
- 235000013336 milk Nutrition 0.000 abstract description 6
- 239000008267 milk Substances 0.000 abstract description 6
- 210000004080 milk Anatomy 0.000 abstract description 6
- 238000005336 cracking Methods 0.000 abstract description 3
- 230000009747 swallowing Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 19
- 239000000203 mixture Substances 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 7
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 235000013350 formula milk Nutrition 0.000 description 4
- 238000011049 filling Methods 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000004641 brain development Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002270 gangliosides Chemical class 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- SQVRNKJHWKZAKO-LUWBGTNYSA-N N-acetylneuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-LUWBGTNYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010041662 Splinter Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000031142 liver development Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000003988 neural development Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
样品 | 是否裂片 | 是否坍塌 | 缩片程度 |
实施例1 | 否 | 否 | 0% |
实施例2 | 否 | 否 | 0% |
实施例3 | 否 | 否 | 0% |
对比例1 | 是 | 否 | 12.3% |
对比例2 | 是 | 是 | / |
对比例3 | 否 | 否 | 0% |
对比例4 | 否 | 否 | 0% |
对比例5 | 否 | 是 | / |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110366255.XA CN113069425B (zh) | 2021-04-06 | 2021-04-06 | N-乙酰神经氨酸含化糖冻干闪释片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110366255.XA CN113069425B (zh) | 2021-04-06 | 2021-04-06 | N-乙酰神经氨酸含化糖冻干闪释片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113069425A true CN113069425A (zh) | 2021-07-06 |
CN113069425B CN113069425B (zh) | 2022-04-15 |
Family
ID=76615000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110366255.XA Active CN113069425B (zh) | 2021-04-06 | 2021-04-06 | N-乙酰神经氨酸含化糖冻干闪释片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113069425B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115429764A (zh) * | 2022-09-14 | 2022-12-06 | 合肥中科健康生物产业技术研究院有限公司 | 一种冻干闪释片及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1689649A (zh) * | 2004-04-30 | 2005-11-02 | 量子高科(北京)研究院有限公司 | 一种口腔速溶制剂及其生产方法 |
WO2011058336A2 (en) * | 2009-11-16 | 2011-05-19 | Aston University | Tablet |
CN109757686A (zh) * | 2019-02-27 | 2019-05-17 | 东莞百润生物科技有限公司 | 一种含n-乙酰神经氨酸的蛋白粉食品及其制备方法 |
-
2021
- 2021-04-06 CN CN202110366255.XA patent/CN113069425B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1689649A (zh) * | 2004-04-30 | 2005-11-02 | 量子高科(北京)研究院有限公司 | 一种口腔速溶制剂及其生产方法 |
WO2011058336A2 (en) * | 2009-11-16 | 2011-05-19 | Aston University | Tablet |
CN109757686A (zh) * | 2019-02-27 | 2019-05-17 | 东莞百润生物科技有限公司 | 一种含n-乙酰神经氨酸的蛋白粉食品及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115429764A (zh) * | 2022-09-14 | 2022-12-06 | 合肥中科健康生物产业技术研究院有限公司 | 一种冻干闪释片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN113069425B (zh) | 2022-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI621443B (zh) | 中藥組合物及其用途、包含該中藥組合物之藥物製劑及複方丹參微滴丸劑、及該微滴丸劑的製備方法 | |
JP2020203931A (ja) | 漢方薬組成物、及びそれらの製剤及び用途 | |
CN113069425B (zh) | N-乙酰神经氨酸含化糖冻干闪释片及其制备方法 | |
JP2023525627A (ja) | 新型コロナウィルス肺炎の予防および/または治療のための医薬の製造における漢方薬組成物およびその製剤の使用 | |
CN105193747B (zh) | 一种含有阿戈美拉汀的冻干口服制剂及其制备方法 | |
CN102631336B (zh) | 小儿维生素k1组合物冻干口腔崩解片及其制备方法 | |
CN113750058B (zh) | 一种间苯三酚冻干口崩片及其制备方法 | |
CN113081981B (zh) | 乳糖酶冻干闪释片及其制备方法 | |
CN102600119B (zh) | 一种小儿对乙酰氨基酚组合物 | |
CN112971150B (zh) | γ-氨基丁酸含化糖冻干闪释片及其制备方法 | |
CN104069074B (zh) | 一种注射用奥拉西坦及其制备方法 | |
WO2021219112A1 (zh) | 异戊酰螺旋霉素类化合物或其组合物在制备治疗脓毒症疾病药物中的应用 | |
KR101269911B1 (ko) | 홍삼 오일을 부형제 오일로 함유하는 연질캡슐제 | |
CN102429879A (zh) | 一种盐酸氨溴索脂质体注射剂 | |
CN113069424B (zh) | 益生菌含化糖冻干闪释片及其制备方法 | |
CN101849991B (zh) | 一种辛夷挥发油纳米脂质体冻干粉及其温敏型辛夷纳米凝胶和制备方法 | |
CN1872107B (zh) | α受体阻断的中西复方制剂及其制备方法和应用 | |
CN116019773A (zh) | 一种苯磺酸氨氯地平冻干口腔崩解片及其制备方法 | |
CN102600153B (zh) | 小儿复方氢溴酸山莨宕碱与马来酸氯苯那敏冻干口崩片及其制备方法 | |
CN109846841B (zh) | 一种速效氯巴占口服冻干制剂及其制备方法 | |
CN100358500C (zh) | 灯盏地龙滴丸 | |
CN100548307C (zh) | 一种治疗心脑血管疾病的药物 | |
CN1872108B (zh) | 一种积雪草总苷滴丸及其制备方法 | |
CN100430070C (zh) | 一种治疗冠心病心绞痛的药物 | |
CN114028351A (zh) | 一种利司扑兰冻干口崩片及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220429 Address after: 061754 exhibition culture industrial park, Cangzhou Economic Development Zone, Jiefang East Road, Cangzhou Economic Development Zone, Cangzhou City, Hebei Province Patentee after: Hebei Feirui Biotechnology Co.,Ltd. Address before: 101111 room 1602, building 3, 88 Kechuang Sixth Street, Beijing Yizhuang Economic and Technological Development Zone, Daxing District, Beijing Patentee before: Beijing feiruiyanglin pharmaceutical technology research and Development Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230626 Address after: Building 3, No. 12, Wuchu Avenue, Fankou Street, Echeng District, Ezhou, Hubei Province, 436000 Patentee after: Hubei Feirui Biopharmaceutical Co.,Ltd. Address before: 061754 exhibition culture industrial park, Cangzhou Economic Development Zone, Jiefang East Road, Cangzhou Economic Development Zone, Cangzhou City, Hebei Province Patentee before: Hebei Feirui Biotechnology Co.,Ltd. |